Related Articles
Tumor-penetration and antitumor efficacy of cetuximab are enhanced by co-administered iRGD in a murine model of human NSCLC
Tumor‑penetrating peptide fused EGFR single‑domain antibody enhances radiation responses following EGFR inhibition in gastric cancer Corrigendum in /10.3892/or.2020.7834
Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy
Coupling Gd‑DTPA with a bispecific, recombinant protein anti‑EGFR‑iRGD complex improves tumor targeting in MRI
Vasoactive intestinal peptide receptor-based imaging and treatment of tumors (Review)